Nissay Asset Management’s AstraZeneca AZN Stock Holding History

Nissay Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.15M	Buy	+16,631	New	+$3.13M	0.01%	450
2026 Q1	–	Sell	-42,052	Closed	-$7.73M	–	670
2025 Q4	$7.73M	Buy	42,052 +3,143	+8%	+$551K	0.04%	258
2025 Q3	$5.97M	Buy	38,909 +386	+1%	+$58.4K	0.03%	286
2025 Q2	$5.38M	Buy	38,523 +2,887	+8%	+$405K	0.03%	312
2025 Q1	$5.24M	Buy	35,636 +6,029	+20%	+$872K	0.03%	312
2024 Q4	$3.92M	Buy	29,607 +3,504	+13%	+$491K	0.02%	366
2024 Q3	$4.07M	Buy	26,103 +4,097	+19%	+$661K	0.03%	365
2024 Q2	$3.43M	Buy	22,006 +5,293	+32%	+$796K	0.02%	380
2024 Q1	$2.26M	Buy	16,713 +11,795	+240%	+$1.56M	0.02%	473
2023 Q4	$662K	Buy	4,918 +2,516	+105%	+$327K	0.01%	667
2023 Q3	$325K	Buy	+2,402	New	+$328K	﹤0.01%	725

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nissay Asset Management's AZN Position: Q2 2026 in Review

Nissay Asset Management opened a new position in AstraZeneca (AZN) in Q2 2026: 16,631 shares worth $3.15M. The stake represents 0.01% of the portfolio and ranks #450 among its holdings. This is a return to the name: Nissay Asset Management previously reported a position in AZN as recently as Q4 2025.

Nissay Asset Management first reported a position in AZN in Q3 2023 and has held it in 11 quarters since. The position peaked at $7.73M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Nissay Asset Management held 16,631 shares of AstraZeneca worth $3.15M as of Q2 2026.
AstraZeneca was a new Nissay Asset Management position in Q2 2026.
AstraZeneca made up 0.01% of Nissay Asset Management's portfolio in Q2 2026, its #450 holding.
Nissay Asset Management first reported a position in AstraZeneca in Q3 2023 and has held it in 11 quarters since.
Nissay Asset Management's AstraZeneca position peaked at $7.73M in Q4 2025.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Nissay Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.